Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Prior Notice of Imported Food, 30713-30715 [2020-10825]

Download as PDF 30713 Federal Register / Vol. 85, No. 98 / Wednesday, May 20, 2020 / Notices TABLE 3—ESTIMATED ANNUAL THIRD-PARTY DISCLOSURE BURDEN 1 Number of respondents 21 CFR section; activity 101.3, 101.22, parts 102 and 104; statement of identity labeling requirements ......... 101.4, 101.22, 101.100, parts 102, 104 and 105; ingredient labeling requirements ... 101.5; requirement to specify the name and place of business of the manufacturer, packer, or distributor and, if the food producer is not the manufacturer of the food product, its connection with the food product. 101.9, 101.13(n), 101.14(d)(3), 101.62, and part 104; labeling requirements for disclosure of nutrition information. 101.9(g)(9) and 101.36(f)(2); alternative means of compliance permitted .................. 101.10; requirements for nutrition labeling of restaurant foods ................................... 101.12(b); RACC for baking powder, baking soda, and pectin ................................... 101.12(e); adjustment to the RACC of an aerated food permitted .............................. 101.12(g); requirement to disclose the serving size that is the basis for a claim made for the product if the serving size on which the claim is based differs from the RACC. 101.13(d)(1) and 101.67; requirements to disclose nutrition information for any food product for which a nutrient content claim is made. 101.13(j)(2) and (k), 101.54, 101.56, 101.60, 101.61, and 101.62; additional disclosure required if the nutrient content claim compares the level of a nutrient in one food with the level of the same nutrient in another food. 101.13(q)(5); requirement that restaurants disclose the basis for nutrient content claims made for their food. 101.14(d)(2); general requirements for disclosure of nutrition information related to health claims for food products. 101.15; requirements pertaining to prominence of required statements and use of foreign language. 101.22(i)(4); supplier certifications for flavors designated as containing no artificial flavors. 101.30 and 102.33; labeling requirements for fruit or vegetable juice beverages ...... 101.36; nutrition labeling of dietary supplements ......................................................... 101.42 and 101.45; nutrition labeling of raw fruits, vegetables, and fish .................... 101.45(c); databases of nutrient values for raw fruits, vegetables, and fish ............... 101.79(c)(2)(i)(D); disclosure requirements for food labels that contain a folate/neural tube defect health claim. 101.79(c)(2)(iv); disclosure of amount of folate for food labels that contain a folate/ neural tube defect health claim. 101.100(d); disclosure of agreements that form the basis for exemption from the labeling requirements of section 403(c), (e), (g)–(i), (k), and (q) of the FD&C Act. 101.7 and 101.100(h); disclosure requirements for food not accurately labeled for quantity of contents and for claiming certain labeling exemptions. Nutritional labeling for new products ............................................................................ Total ....................................................................................................................... 1 There Number of disclosures per respondent Total annual disclosures Average burden per disclosure Total hours 25,000 25,000 25,000 1.03 1.03 1.03 25,750 25,750 25,750 0.5 (30 minutes) ..... 1 ............................. 0.25 (15 minutes) ... 12,875 25,750 6,438 25,000 1.03 25,750 4 ............................. 103,000 12 300,000 29 25 5,000 1 1.5 2.3 1 1 12 450,000 67 25 5,000 4 ............................. 0.25 (15 minutes) ... 1 ............................. 1 ............................. 1 ............................. 48 112,500 67 25 5,000 200 1 200 1 ............................. 200 5,000 1 5,000 1 ............................. 5,000 300,000 1.5 450,000 0.75 (45 minutes) ... 337,500 300,000 1.5 450,000 0.75 (45 minutes) ... 337,500 160 10 1,600 8 ............................. 12,800 25 1 25 1 ............................. 25 1,500 300 1,000 5 1,000 5 40 1 4 1 7,500 12,000 1,000 20 1,000 1 ............................. 4.025 ...................... 0.5 (30 minutes) ..... 4 ............................. 0.25 (15 minutes) ... 7,500 48,300 500 80 250 100 1 100 0.25 (15 minutes) ... 25 1,000 1 1,000 1 ............................. 1,000 25,000 1.03 25,750 0.5 (30 minutes) ..... 12,875 500 1 500 2 ............................. 1,000 .................... .................... 1,513,799 ................................ 1,030,258 are no capital costs or operating and maintenance costs associated with this collection of information. Because of the consolidation of OMB control number 0910–0813, our estimate reflects an annual increase of 188,442 responses and 188,282 hours. These estimates are based on our experience with food labeling, related submissions of petitions, and informal communications with industry. Dated: May 7, 2020. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2020–10824 Filed 5–19–20; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2010–N–0118] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Prior Notice of Imported Food AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Submit written comments (including recommendations) on the SUMMARY: VerDate Sep<11>2014 17:51 May 19, 2020 Jkt 250001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 collection of information by June 19, 2020. ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be submitted to https:// www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under Review—Open for Public Comments’’ or by using the search function. The OMB control number for this information collection is 0910–0520. Also include the FDA docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Domini Bean, Office of Operations, Food and Drug Administration, Three White Flint North, 10A–12M, 11601 Landsdown St., North Bethesda, MD 20852, 301–796–5733, PRAStaff@ fda.hhs.gov. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA E:\FR\FM\20MYN1.SGM 20MYN1 30714 Federal Register / Vol. 85, No. 98 / Wednesday, May 20, 2020 / Notices in managing the potential risks of imported food shipments into the United States. Any person with knowledge of the required information may submit prior notice for an article of food. Thus, the respondents to this information collection may include importers, owners, ultimate consignees, shippers, and carriers. FDA regulations require that prior notice of imported food be submitted electronically using CBP’s Automated Broker Interface of the Automated Commercial System (ABI/ACS) (§ 1.280(a)(1)) or the FDA Prior Notice System Interface (PNSI) (Form FDA 3540) (§ 1.280(a)(2)). PNSI is an electronic submission system available on the FDA Industry Systems page at https://www.access.fda.gov. Information the Agency collects in the prior notice submission includes: (1) The submitter and transmitter (if different from the submitter); (2) entry type and CBP identifier; (3) the article of food, including complete FDA product code; (4) the manufacturer, for an article of food no longer in its natural state; (5) the grower, if known, for an article of food that is in its natural state; (6) the FDA Country of Production; (7) the name of any country that has refused entry of the article of food; (8) the shipper, except for food imported by international mail; (9) the country from which the article of food is shipped or, if the food is imported by international mail, the anticipated date of mailing and country from which the food is mailed; (10) the anticipated arrival information or, if the food is imported by international mail, the U.S. recipient; (11) the importer, owner, and ultimate consignee, except for food imported by international mail or transshipped through the United States; (12) the carrier and mode of transportation, except for food imported by international mail; and (13) planned shipment information, except for food imported by international mail (§ 1.281). Much of the information collected for prior notice is identical to the information collected for FDA has submitted the following proposed collection of information to OMB for review and clearance. Prior Notice of Imported Food—21 CFR 1.278 to 1.285 OMB Control Number 0910–0520— Extension The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 added section 801(m) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 381(m)), which requires that FDA receive prior notice for food, including food for animals, that is imported or offered for import into the United States. Sections 1.278 through 1.282 of FDA regulations (21 CFR 1.278 through 1.282) set forth the requirements for submitting prior notice, §§ 1.283(d) and 1.285(j) (21 CFR 1.283(d) and 1.285(j)) set forth the procedure for requesting Agency review after FDA has refused admission of an article of food under section 801(m)(1) of the FD&C Act or placed an article of food under hold under section 801(l) of the FD&C Act, and § 1.285(i) sets forth the procedure for post-hold submissions. Section 304 of the FDA Food Safety Modernization Act (Pub. L. 111–353) amended section 801(m) of the FD&C Act to require a person submitting prior notice of imported food, including food for animals, to report, in addition to other information already required, ‘‘any country to which the article has been refused entry.’’ Advance notice of imported food allows FDA, with the support of the U.S. Customs and Border Protection (CBP), to target import inspections more effectively and help protect the nation’s food supply against terrorist acts and other public health emergencies. By requiring that a prior notice contain specific information that indicates prior refusals by any country and identifies the country or countries, the Agency may better identify imported food shipments that may pose safety and security risks to U.S. consumers. This information collection enables FDA to make better informed decisions importer’s entry notice, which has been approved under OMB control number 0910–0046. The information in an importer’s entry notice is collected electronically via CBP’s ABI/ACS at the same time the respondent files an entry for import with CBP. To avoid double counting the burden hours already counted in the importer’s entry notice information collection, the burden hour analysis in table 1 reflects FDA’s estimate of the reduced burden for prior notice submitted through ABI/ACS in column 6 entitled ‘‘Average Burden per Response.’’ In addition to submitting a prior notice, a submitter should cancel a prior notice and must resubmit the information to FDA if information changes after the Agency has confirmed a prior notice submission for review (e.g., if the identity of the manufacturer changes) (§ 1.282). However, changes in the estimated quantity, anticipated arrival information, or planned shipment information do not require resubmission of prior notice after the Agency has confirmed a prior notice submission for review (§ 1.282(a)(1)(i) to (iii)). In the event that FDA refuses admission to an article of food under section 801(m)(1) or the Agency places it under hold under section 801(l) of the FD&C Act, §§ 1.283(d) and 1.285(j) set forth the procedure for requesting FDA’s review and the information required in a request for review. In the event that the Agency places an article of food under hold under section 801(l) of the FD&C Act, § 1.285(i) sets forth the procedure for, and the information to be included in, a post-hold submission. In the Federal Register of February 6, 2020 (85 FR 6955), we published a 60day notice requesting public comment on the proposed collection of information. One comment was received but was not responsive to the four information collection topics solicited and therefore is not addressed. We estimate the burden of the information collection as follows: TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1 FDA Form No. 21 CFR section Number of respondents Number of responses per respondent Total annual responses Average burden per response Total hours Prior Notice Submissions: Through ABI/ACS 1.280 through 1.281 .................... N/A 1,700 7,647 12,999,900 0.167 (10 minutes) ..... 2 2,170,983 1,890,000 0.384 (23 minutes) ..... 725,760 Through PNSI 1.280 through 1.281 .................... VerDate Sep<11>2014 17:51 May 19, 2020 Jkt 250001 3 3540 PO 00000 27,000 Frm 00033 Fmt 4703 70 Sfmt 4703 E:\FR\FM\20MYN1.SGM 20MYN1 Federal Register / Vol. 85, No. 98 / Wednesday, May 20, 2020 / Notices 30715 TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued 21 CFR section Subtotal ................................ FDA Form No. Number of respondents Number of responses per respondent Total annual responses Average burden per response ........................ ........................ ........................ ........................ ..................................... 2,896,743 1 7,040 0.25 (15 minutes) ....... 1,760 Total hours Cancellations: Through ABI/ACS 1.282 ........................................... 3540 7,040 Through PNSI 1.282 and 1.283(a)(5) ................. 3540 35,208 1 35,208 0.25 (15 minutes) ....... 8,802 Subtotal ................................ ........................ ........................ ........................ ........................ ..................................... 10,562 Requests for Review and Post-hold Submissions 1.283(d) and 1.285(j), ................. 1.285(i) ........................................ N/A N/A 1 263 1 1 1 263 8 ................................. 1 ................................. 8 263 Subtotal ................................ ........................ ........................ ........................ ........................ ..................................... 271 Total .............................. ........................ ........................ ........................ 14,932,412 ..................................... 2,907,576 1 There are no capital costs or operating and maintenance costs associated with this collection of information. avoid double counting, an estimated 396,416 burden hours already accounted for in the importer’s entry notice information collection approved under OMB control number 0910–0046 are not included in this total. 3 The term ‘‘Form FDA 3540’’ refers to the electronic submission system known as PNSI, which is available at https://www.access.fda.gov. 2 To Based on our experience and the average number of prior notice submissions, cancellations, and requests for review received in the past 3 years, we have made no adjustments in our burden estimate for the information collection. We estimate that 1,700 users of ABI/ACS will submit an average of 7,647 prior notices annually, for a total of 12,999,900 prior notices received through ABI/ACS. We assume the reporting burden for a prior notice submitted through ABI/ACS to be 10 minutes, or 0.167 hour, per notice, for a total annual burden of 2,170,983 hours. This estimate takes into consideration the burden hours already counted in the information collection approval for FDA importer’s entry notice (OMB control number 0910– 0046), as previously discussed. We estimate that 27,000 registered users of PNSI will submit an average of 70 prior notices annually, for a total of 1,890,000 prior notices received annually. We assume the reporting burden for a prior notice submitted through PNSI to be 23 minutes, or 0.384 hour, per notice, for a total burden of 725,760 hours. We estimate that 7,040 users of ABI/ ACS will submit an average of 1 cancellation annually, for a total of 7,040 cancellations received annually through ABI/ACS. We assume the reporting burden for a cancellation submitted through ABI/ACS to be 15 minutes, or 0.25 hour, per cancellation, for a total burden of 1,760 hours. VerDate Sep<11>2014 17:51 May 19, 2020 Jkt 250001 We estimate that 35,208 registered users of PNSI will submit an average of 1 cancellation annually, for a total of 35,208 cancellations received annually. We assume the reporting burden for a cancellation submitted through PNSI to be 15 minutes, or 0.25 hour, per cancellation, for a total burden of 8,802 hours. We estimate that one or fewer requests for review under § 1.283(d) or § 1.285(j) will be submitted annually. We assume that it will take respondents 8 hours to prepare the factual and legal information necessary to prepare a request for review. Thus, we estimate a total reporting burden of 8 hours. We estimate that 263 post-hold submissions under § 1.285(i) will be submitted annually. We assume that it will take about 1 hour to prepare the written notification described in § 1.285(i)(2), for a total reporting burden of 263 hours. Dated: May 12, 2020. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2020–10825 Filed 5–19–20; 8:45 am] BILLING CODE 4164–01–P PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; Research Education on Alzheimer’s Disease and Related Dementias. Date: June 4, 2020. Time: 2:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Kimberly Firth, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, National Institutes of Health, Gateway Building, 7201 Wisconsin Avenue, Suite 2W200, Bethesda, E:\FR\FM\20MYN1.SGM 20MYN1

Agencies

[Federal Register Volume 85, Number 98 (Wednesday, May 20, 2020)]
[Notices]
[Pages 30713-30715]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10825]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0118]


Agency Information Collection Activities; Submission for Office 
of Management and Budget Review; Comment Request; Prior Notice of 
Imported Food

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
proposed collection of information has been submitted to the Office of 
Management and Budget (OMB) for review and clearance under the 
Paperwork Reduction Act of 1995.

DATES: Submit written comments (including recommendations) on the 
collection of information by June 19, 2020.

ADDRESSES: To ensure that comments on the information collection are 
received, OMB recommends that written comments be submitted to https://www.reginfo.gov/public/do/PRAMain. Find this particular information 
collection by selecting ``Currently under Review--Open for Public 
Comments'' or by using the search function. The OMB control number for 
this information collection is 0910-0520. Also include the FDA docket 
number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Domini Bean, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 301-796-5733, 
[email protected].

SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA

[[Page 30714]]

has submitted the following proposed collection of information to OMB 
for review and clearance.

Prior Notice of Imported Food--21 CFR 1.278 to 1.285

OMB Control Number 0910-0520--Extension

    The Public Health Security and Bioterrorism Preparedness and 
Response Act of 2002 added section 801(m) of the Federal Food, Drug, 
and Cosmetic Act (FD&C Act) (21 U.S.C. 381(m)), which requires that FDA 
receive prior notice for food, including food for animals, that is 
imported or offered for import into the United States. Sections 1.278 
through 1.282 of FDA regulations (21 CFR 1.278 through 1.282) set forth 
the requirements for submitting prior notice, Sec. Sec.  1.283(d) and 
1.285(j) (21 CFR 1.283(d) and 1.285(j)) set forth the procedure for 
requesting Agency review after FDA has refused admission of an article 
of food under section 801(m)(1) of the FD&C Act or placed an article of 
food under hold under section 801(l) of the FD&C Act, and Sec.  
1.285(i) sets forth the procedure for post-hold submissions.
    Section 304 of the FDA Food Safety Modernization Act (Pub. L. 111-
353) amended section 801(m) of the FD&C Act to require a person 
submitting prior notice of imported food, including food for animals, 
to report, in addition to other information already required, ``any 
country to which the article has been refused entry.'' Advance notice 
of imported food allows FDA, with the support of the U.S. Customs and 
Border Protection (CBP), to target import inspections more effectively 
and help protect the nation's food supply against terrorist acts and 
other public health emergencies. By requiring that a prior notice 
contain specific information that indicates prior refusals by any 
country and identifies the country or countries, the Agency may better 
identify imported food shipments that may pose safety and security 
risks to U.S. consumers.
    This information collection enables FDA to make better informed 
decisions in managing the potential risks of imported food shipments 
into the United States. Any person with knowledge of the required 
information may submit prior notice for an article of food. Thus, the 
respondents to this information collection may include importers, 
owners, ultimate consignees, shippers, and carriers.
    FDA regulations require that prior notice of imported food be 
submitted electronically using CBP's Automated Broker Interface of the 
Automated Commercial System (ABI/ACS) (Sec.  1.280(a)(1)) or the FDA 
Prior Notice System Interface (PNSI) (Form FDA 3540) (Sec.  
1.280(a)(2)). PNSI is an electronic submission system available on the 
FDA Industry Systems page at https://www.access.fda.gov. Information 
the Agency collects in the prior notice submission includes: (1) The 
submitter and transmitter (if different from the submitter); (2) entry 
type and CBP identifier; (3) the article of food, including complete 
FDA product code; (4) the manufacturer, for an article of food no 
longer in its natural state; (5) the grower, if known, for an article 
of food that is in its natural state; (6) the FDA Country of 
Production; (7) the name of any country that has refused entry of the 
article of food; (8) the shipper, except for food imported by 
international mail; (9) the country from which the article of food is 
shipped or, if the food is imported by international mail, the 
anticipated date of mailing and country from which the food is mailed; 
(10) the anticipated arrival information or, if the food is imported by 
international mail, the U.S. recipient; (11) the importer, owner, and 
ultimate consignee, except for food imported by international mail or 
transshipped through the United States; (12) the carrier and mode of 
transportation, except for food imported by international mail; and 
(13) planned shipment information, except for food imported by 
international mail (Sec.  1.281).
    Much of the information collected for prior notice is identical to 
the information collected for FDA importer's entry notice, which has 
been approved under OMB control number 0910-0046. The information in an 
importer's entry notice is collected electronically via CBP's ABI/ACS 
at the same time the respondent files an entry for import with CBP. To 
avoid double counting the burden hours already counted in the 
importer's entry notice information collection, the burden hour 
analysis in table 1 reflects FDA's estimate of the reduced burden for 
prior notice submitted through ABI/ACS in column 6 entitled ``Average 
Burden per Response.''
    In addition to submitting a prior notice, a submitter should cancel 
a prior notice and must resubmit the information to FDA if information 
changes after the Agency has confirmed a prior notice submission for 
review (e.g., if the identity of the manufacturer changes) (Sec.  
1.282). However, changes in the estimated quantity, anticipated arrival 
information, or planned shipment information do not require 
resubmission of prior notice after the Agency has confirmed a prior 
notice submission for review (Sec.  1.282(a)(1)(i) to (iii)). In the 
event that FDA refuses admission to an article of food under section 
801(m)(1) or the Agency places it under hold under section 801(l) of 
the FD&C Act, Sec. Sec.  1.283(d) and 1.285(j) set forth the procedure 
for requesting FDA's review and the information required in a request 
for review. In the event that the Agency places an article of food 
under hold under section 801(l) of the FD&C Act, Sec.  1.285(i) sets 
forth the procedure for, and the information to be included in, a post-
hold submission.
    In the Federal Register of February 6, 2020 (85 FR 6955), we 
published a 60-day notice requesting public comment on the proposed 
collection of information. One comment was received but was not 
responsive to the four information collection topics solicited and 
therefore is not addressed.
    We estimate the burden of the information collection as follows:

                                                     Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                         Number of
           21 CFR section              FDA Form No.      Number of     responses per   Total annual       Average burden per response       Total hours
                                                        respondents     respondent       responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                Prior Notice Submissions:
                                                                     Through ABI/ACS
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.280 through 1.281.................             N/A           1,700           7,647      12,999,900  0.167 (10 minutes)................   \2\ 2,170,983
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                      Through PNSI
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.280 through 1.281.................        \3\ 3540          27,000              70       1,890,000  0.384 (23 minutes)................         725,760
                                     -------------------------------------------------------------------------------------------------------------------

[[Page 30715]]

 
    Subtotal........................  ..............  ..............  ..............  ..............  ..................................       2,896,743
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                     Cancellations:
                                                                     Through ABI/ACS
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.282...............................            3540           7,040               1           7,040  0.25 (15 minutes).................           1,760
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                      Through PNSI
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.282 and 1.283(a)(5)...............            3540          35,208               1          35,208  0.25 (15 minutes).................           8,802
                                     -------------------------------------------------------------------------------------------------------------------
    Subtotal........................  ..............  ..............  ..............  ..............  ..................................          10,562
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                      Requests for Review and Post-hold Submissions
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.283(d) and 1.285(j),..............             N/A               1               1               1  8.................................               8
1.285(i)............................             N/A             263               1             263  1.................................             263
                                     -------------------------------------------------------------------------------------------------------------------
    Subtotal........................  ..............  ..............  ..............  ..............  ..................................             271
                                     -------------------------------------------------------------------------------------------------------------------
        Total.......................  ..............  ..............  ..............      14,932,412  ..................................       2,907,576
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
\2\ To avoid double counting, an estimated 396,416 burden hours already accounted for in the importer's entry notice information collection approved
  under OMB control number 0910-0046 are not included in this total.
\3\ The term ``Form FDA 3540'' refers to the electronic submission system known as PNSI, which is available at https://www.access.fda.gov.

    Based on our experience and the average number of prior notice 
submissions, cancellations, and requests for review received in the 
past 3 years, we have made no adjustments in our burden estimate for 
the information collection. We estimate that 1,700 users of ABI/ACS 
will submit an average of 7,647 prior notices annually, for a total of 
12,999,900 prior notices received through ABI/ACS. We assume the 
reporting burden for a prior notice submitted through ABI/ACS to be 10 
minutes, or 0.167 hour, per notice, for a total annual burden of 
2,170,983 hours. This estimate takes into consideration the burden 
hours already counted in the information collection approval for FDA 
importer's entry notice (OMB control number 0910-0046), as previously 
discussed.
    We estimate that 27,000 registered users of PNSI will submit an 
average of 70 prior notices annually, for a total of 1,890,000 prior 
notices received annually. We assume the reporting burden for a prior 
notice submitted through PNSI to be 23 minutes, or 0.384 hour, per 
notice, for a total burden of 725,760 hours.
    We estimate that 7,040 users of ABI/ACS will submit an average of 1 
cancellation annually, for a total of 7,040 cancellations received 
annually through ABI/ACS. We assume the reporting burden for a 
cancellation submitted through ABI/ACS to be 15 minutes, or 0.25 hour, 
per cancellation, for a total burden of 1,760 hours.
    We estimate that 35,208 registered users of PNSI will submit an 
average of 1 cancellation annually, for a total of 35,208 cancellations 
received annually. We assume the reporting burden for a cancellation 
submitted through PNSI to be 15 minutes, or 0.25 hour, per 
cancellation, for a total burden of 8,802 hours.
    We estimate that one or fewer requests for review under Sec.  
1.283(d) or Sec.  1.285(j) will be submitted annually. We assume that 
it will take respondents 8 hours to prepare the factual and legal 
information necessary to prepare a request for review. Thus, we 
estimate a total reporting burden of 8 hours.
    We estimate that 263 post-hold submissions under Sec.  1.285(i) 
will be submitted annually. We assume that it will take about 1 hour to 
prepare the written notification described in Sec.  1.285(i)(2), for a 
total reporting burden of 263 hours.

    Dated: May 12, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-10825 Filed 5-19-20; 8:45 am]
 BILLING CODE 4164-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.